Courtney J M, Sundaram S, Matata B M, Gaylor J D
Bioengineering Unit, University of Strathclyde, Glasgow, UK.
Perfusion. 1994 Jan;9(1):3-10. doi: 10.1177/026765919400900102.
The improved utilization of biomaterials in cardiopulmonary bypass is dependent on polymer science and technology, procedures for blood compatibility assessment, optimization of biomaterial/antithrombotic agent combinations and the interpretation of clinical data.